...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AACR 2019
Reply New Message
Back To Forum List View
Icon president AACR 2019
4
BearDownAZ
Feb 27, 2019 10:45PM
Re: AACR 2019

narmac
Feb 28, 2019 06:30AM
Icon president Re: AACR 2019
3
BearDownAZ
Feb 28, 2019 08:33AM
Icon president Re: AACR 2019
3
BearDownAZ
Feb 28, 2019 10:18AM
Re: AACR 2019
1
narmac
Feb 28, 2019 11:26AM
Icon president Re: AACR 2019
2
BearDownAZ
Feb 28, 2019 11:39AM

https://www.researchgate.net/publicationrs

Abstract P3-06-07: The BET bromodomain inhibitors ZEN-3694 and ZEN-3309 targets several mechanisms of resistance to endocrine therapies in preclinical models of ER+ breast cancers

2 Recommendations
Re: AACR 2019
1
narmac
Feb 28, 2019 11:46AM
Icon president Re: AACR 2019
3
BearDownAZ
Feb 28, 2019 01:48PM
Re: AACR 2019
7
KayakerBC
Feb 28, 2019 02:07PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply